The Swiss market closed weakly on Tuesday as stocks slipped after a slightly positive move in early trading. The benchmark SMI closed down 0.47% at 12,296.72 as investors remained cautious ahead of key economic data from the US. In such an environment, identifying high-growth technology stocks with potentially high returns is crucial for investors looking to navigate market volatility and capitalize on new opportunities in the Swiss technology sector.

The 10 fastest growing technology companies in Switzerland

Click here to see the full list of 10 stocks from our SIX Swiss Exchange High Growth Tech and AI Stocks screener.

Let’s take a look at some of the best options from the screener.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Basilea Pharmaceutica Ltd. is a commercial-stage biopharmaceutical company focused on the development of oncology and anti-infective products with a market capitalization of CHF 540.60 million.

Operations: Basilea Pharmaceutica Ltd. focuses on the discovery, development and commercialization of innovative pharmaceutical products in the areas of oncology and anti-infectives and generates sales of CHF 149.02 million. The company’s business model is focused on addressing unmet medical needs in these therapeutic areas.

Basilea Pharmaceutica recently reached an important milestone: the European Commission expanded the indications of Cresemba® to pediatric patients, resulting in a payment of CHF 10 million from Pfizer. Despite a forecast annual sales growth of 9.9%, the latest earnings reports show a decline in net profit from CHF 31.8 million last year to CHF 20.74 million. The company’s R&D expenses reflect its commitment to innovation and contribute significantly to the future profitability forecasts of 36.82% annual growth over the next three years.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: LEM Holding SA, together with its subsidiaries, provides solutions for measuring electrical parameters in various regions of the world, including China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America. The company has a market capitalization of CHF 1.39 billion.

The story continues

Operations: LEM Holding SA specializes in providing solutions for measuring electrical parameters in different regions of the world. The company generates its revenue mainly through the sale of these measurement solutions, with markets in Asia, Europe and America also making a significant contribution.

LEM Holding’s recent performance has been mixed. First-quarter sales fell from CHF 112.34 million last year to CHF 80.96 million and net profit fell from CHF 20.54 million to CHF 4.78 million. Despite these challenges, the company is poised for future growth and expects annual profit growth of 18.4%, outperforming the Swiss market average of 11.9%. It is particularly noteworthy that LEM Holding invests significantly in research and development, spending CHF 40 million last year to drive innovation in the field of electronic components.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Temenos AG develops, markets and sells integrated banking software systems to financial institutions worldwide with a market capitalization of CHF 4.26 billion.

Operations: The company generates its revenue by providing integrated banking software systems to financial institutions worldwide. With a market capitalization of CHF 4.26 billion, its main sources of revenue include software licenses, maintenance fees and professional services.

Temenos is leveraging its strong SaaS capabilities to drive its growth, as demonstrated by Haventree Bank’s recent choice of Temenos for digital transformation. The company’s R&D spending underscores its commitment to innovation; last year it spent CHF 40 million. Revenue forecasts show a stable annual growth rate of 7.6%, outperforming the Swiss market at 4.4%. Earnings are expected to grow by an impressive 14.3% per year, reflecting solid financial health and strategic positioning in the software industry.

Key findings

Interested in other options?

This Simply Wall St article is of a general nature. We comment solely on historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.

Companies discussed in this article include SWX:BSLN, SWX:LEHN and SWX:TEMN.

Do you have feedback on this article? Are you interested in the content? Contact us directly. Alternatively, send an email to [email protected]